Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 42
Filtrar
1.
Pharm Res ; 40(3): 765-775, 2023 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-36653519

RESUMO

PURPOSE: Preclinical aerosol studies using animals are essential for evaluating toxic or therapeutic effects on human respiratory tract. Macaques are relevant animal models for respiratory studies, but they are sensitive, expensive and difficult-to-access. METHODS: In the context of preliminary studies before animal experiments, we set up an alternative in vitro anatomical model of macaque airways to reduce, refine and replace (3Rs) the animals. We printed an in vitro anatomical cast until the third bronchial division from X-ray computed tomography data of a healthy cynomolgus macaque. This in vitro model was then connected to a respiratory pump to mimic macaque's breathing. We assessed the relevance of this in vitro model, by comparing aerosol deposition patterns obtained with the anatomical model and in three macaques using planar gamma camera imaging. DTPA-99mTechnetium aerosols were produced using three jet nebulizers, generating three different particle sizes: 13.1, 3.2 and 0.93 µm in terms of the mass median aerodynamic diameter (MMAD). RESULTS: The data showed no statistical differences between the animal and anatomical in vitro models in terms of total aerosol deposited in the airways. However, the distribution of the deposition in the airways showed a higher deposited fraction in the upper respiratory tract in the animals than the in vitro model for all particle sizes. CONCLUSIONS: The anatomical printed model appears to be a relevant in vitro tool to predict total aerosol deposition in macaque airways.


Assuntos
Pulmão , Nebulizadores e Vaporizadores , Animais , Humanos , Administração por Inalação , Aerossóis , Macaca , Impressão Tridimensional , Tamanho da Partícula
2.
BMC Genomics ; 15: 987, 2014 Nov 18.
Artigo em Inglês | MEDLINE | ID: mdl-25407482

RESUMO

BACKGROUND: Arthropod venoms are invaluable sources of bioactive substances with biotechnological application. The limited availability of some venoms, such as those from ants, has restricted the knowledge about the composition and the potential that these biomolecules could represent. In order to provide a global insight on the transcripts expressed in the venom gland of the Brazilian ant species Tetramorium bicarinatum and to unveil the potential of its products, high-throughput approach using Illumina technology has been applied to analyze the genes expressed in active venom glands of this ant species. RESULTS: A total of 212,371,758 pairs of quality-filtered, 100-base-pair Illumina reads were obtained. The de novo assemblies yielded 36,042 contigs for which 27,873 have at least one predicted ORF among which 59.77% produce significant hits in the available databases. The investigation of the reads mapping toxin class revealed a high diversification with the major part consistent with the classical hymenopteran venom protein signature represented by venom allergen (33.3%), followed by a diverse toxin-expression profile including several distinct isoforms of phospholipase A1 and A2, venom serine protease, hyaluronidase, protease inhibitor and secapin. Moreover, our results revealed for the first time the presence of toxin-like peptides that have been previously identified from unrelated venomous animals such as waprin-like (snakes) and agatoxins (spiders and conus).The non-toxin transcripts were mainly represented by contigs involved in protein folding and translation, consistent with the protein-secretory function of the venom gland tissue. Finally, about 40% of the generated contigs have no hits in the databases with 25% of the predicted peptides bearing signal peptide emphasizing the potential of the investigation of these sequences as source of new molecules. Among these contigs, six putative novel peptides that show homologies with previously identified antimicrobial peptides were identified. CONCLUSIONS: To the best of our knowledge, this work reports the first large-scale analysis of genes transcribed by the venomous gland of the ant species T. bicarinatum and helps with the identification of Hymenoptera toxin arsenal. In addition, results from this study demonstrate that de novo transcriptome assembly allows useful venom gene expression analysis in a species lacking a genome sequence database.


Assuntos
Formigas/genética , Perfilação da Expressão Gênica , Sequenciamento de Nucleotídeos em Larga Escala , Transcriptoma , Alérgenos/química , Alérgenos/genética , Sequência de Aminoácidos , Animais , Venenos de Formiga/química , Venenos de Formiga/genética , Venenos de Formiga/metabolismo , Formigas/metabolismo , Biologia Computacional , Proteínas de Insetos/química , Proteínas de Insetos/genética , Anotação de Sequência Molecular , Dados de Sequência Molecular , Especificidade de Órgãos , Filogenia , Alinhamento de Sequência
3.
Mar Drugs ; 10(2): 258-280, 2012 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-22412800

RESUMO

Cone snail venoms are considered an untapped reservoir of extremely diverse peptides, named conopeptides, displaying a wide array of pharmacological activities. We report here for the first time, the presence of high molecular weight compounds that participate in the envenomation cocktail used by these marine snails. Using a combination of proteomic and transcriptomic approaches, we identified glycosyl hydrolase proteins, of the hyaluronidase type (Hyal), from the dissected and injectable venoms ("injectable venom" stands for the venom variety obtained by milking of the snails. This is in contrast to the "dissected venom", which was obtained from dissected snails by extraction of the venom glands) of a fish-hunting cone snail, Conus consors (Pionoconus clade). The major Hyal isoform, Conohyal-Cn1, is expressed as a mixture of numerous glycosylated proteins in the 50 kDa molecular mass range, as observed in 2D gel and mass spectrometry analyses. Further proteomic analysis and venom duct mRNA sequencing allowed full sequence determination. Additionally, unambiguous segment location of at least three glycosylation sites could be determined, with glycans corresponding to multiple hexose (Hex) and N-acetylhexosamine (HexNAc) moieties. With respect to other known Hyals, Conohyal-Cn1 clearly belongs to the hydrolase-type of Hyals, with strictly conserved consensus catalytic donor and positioning residues. Potent biological activity of the native Conohyals could be confirmed in degrading hyaluronic acid. A similar Hyal sequence was also found in the venom duct transcriptome of C. adamsonii (Textilia clade), implying a possible widespread recruitment of this enzyme family in fish-hunting cone snail venoms. These results provide the first detailed Hyal sequence characterized from a cone snail venom, and to a larger extent in the Mollusca phylum, thus extending our knowledge on this protein family and its evolutionary selection in marine snail venoms.


Assuntos
Caramujo Conus/enzimologia , Glicosídeo Hidrolases/metabolismo , Venenos de Moluscos/enzimologia , Sequência de Aminoácidos , Animais , Caramujo Conus/metabolismo , Perfilação da Expressão Gênica , Glicosídeo Hidrolases/química , Glicosilação , Hialuronoglucosaminidase/química , Hialuronoglucosaminidase/metabolismo , Modelos Moleculares , Dados de Sequência Molecular , Peso Molecular , Venenos de Moluscos/metabolismo , N-Glicosil Hidrolases/química , N-Glicosil Hidrolases/metabolismo , Filogenia , Estrutura Secundária de Proteína , Proteômica/métodos , RNA Mensageiro/metabolismo , Homologia de Sequência de Aminoácidos
4.
Mol Immunol ; 135: 147-164, 2021 07.
Artigo em Inglês | MEDLINE | ID: mdl-33895579

RESUMO

Respiratory pathogens represent a great burden for humanity and a potential source of new pandemics, as illustrated by the recent emergence of coronavirus disease 2019 (COVID-19). In recent decades, biotechnological advances have led to the development of numerous innovative therapeutic molecules and vaccine immunogens. However, we still lack effective treatments and vaccines against many respiratory pathogens. More than ever, there is a need for a fast, predictive, preclinical pipeline, to keep pace with emerging diseases. Animal models are key for the preclinical development of disease management strategies. The predictive value of these models depends on their ability to reproduce the features of the human disease, the mode of transmission of the infectious agent and the availability of technologies for monitoring infection. This review focuses on the use of non-human primates as relevant preclinical models for the development of prevention and treatment for human respiratory infections.


Assuntos
Vacinas contra COVID-19/imunologia , COVID-19/imunologia , Modelos Animais de Doenças , SARS-CoV-2/imunologia , Animais , COVID-19/patologia , COVID-19/prevenção & controle , Vacinas contra COVID-19/uso terapêutico , Haplorrinos , Humanos
5.
J Med Chem ; 63(15): 8250-8264, 2020 08 13.
Artigo em Inglês | MEDLINE | ID: mdl-32602722

RESUMO

Animal venoms are rich in hundreds of toxins with extraordinary biological activities. Their exploitation is difficult due to their complexity and the small quantities of venom available from most venomous species. We developed a Venomics approach combining transcriptomic and proteomic characterization of 191 species and identified 20,206 venom toxin sequences. Two complementary production strategies based on solid-phase synthesis and recombinant expression in Escherichia coli generated a physical bank of 3597 toxins. Screened on hMC4R, this bank gave an incredible hit rate of 8%. Here, we focus on two novel toxins: N-TRTX-Preg1a, exhibiting an inhibitory cystine knot (ICK) motif, and N-BUTX-Ptr1a, a short scorpion-CSαß structure. Neither N-TRTX-Preg1a nor N-BUTX-Ptr1a affects ion channels, the known targets of their toxin scaffolds, but binds to four melanocortin receptors with low micromolar affinities and activates the hMC1R/Gs pathway. Phylogenetically, these two toxins form new groups within their respective families and represent novel hMC1R agonists, structurally unrelated to the natural agonists.


Assuntos
Proteômica/métodos , Receptores de Melanocortina/agonistas , Venenos de Escorpião/farmacologia , Sequência de Aminoácidos , Animais , Células HEK293 , Ensaios de Triagem em Larga Escala/métodos , Humanos , Receptores de Melanocortina/metabolismo , Venenos de Escorpião/genética , Venenos de Escorpião/isolamento & purificação , Venenos de Escorpião/metabolismo
6.
Cardiovasc Toxicol ; 17(2): 208-214, 2017 04.
Artigo em Inglês | MEDLINE | ID: mdl-27358047

RESUMO

Sarafotoxin-i3 from Atractaspis irregularis is a long sarafotoxin with an extended C terminus extension. Sarafotoxin-b from Atractaspis engaddensis is shorter by four amino acids. These peptides belong to the endothelin-like peptide family with a high sequence homology and similar three-dimensional structure. They act on endothelin receptors situated on the membrane of endothelial and smooth muscle cells. However, SRTX-i 3, despite a high toxicity, has a very low affinity for endothelin receptors compared to SRTX-b. The present work was carried out in order to compare the precise in vivo cardiovascular effect of SRTX-b and SRTX-i3. Male Wistar rats were anesthetized and mechanically ventilated. Doppler echocardiography was performed to measure left and right ventricular functions. The rats were divided into three groups that received intravenous injections of: saline, SRTX-b or SRTX-i3. All measurements were taken at baseline, at 1 min and at 6 min after injection. Both toxins impaired cardiac output. SRTX-b impaired left ventricular function, while SRTX-i3 increased airway pressures and led to acute right ventricular dilatation associated with a decreased tricuspid annulus peak systolic velocity. SRTX-b and SRTX-i3 appear to exert toxic effects via different mechanisms, SRTX-b impairs left ventricular function, while SRTX-i3 increases airway pressures and impairs right ventricular function.


Assuntos
Sistema Cardiovascular/efeitos dos fármacos , Ecocardiografia Doppler , Hemodinâmica/efeitos dos fármacos , Peptídeos/toxicidade , Função Ventricular Esquerda/efeitos dos fármacos , Função Ventricular Direita/efeitos dos fármacos , Venenos de Víboras/toxicidade , Animais , Pressão Arterial/efeitos dos fármacos , Débito Cardíaco/efeitos dos fármacos , Sistema Cardiovascular/diagnóstico por imagem , Sistema Cardiovascular/fisiopatologia , Masculino , Pressão , Ratos Wistar , Sistema Respiratório/efeitos dos fármacos , Sistema Respiratório/fisiopatologia , Fatores de Tempo , Resistência Vascular/efeitos dos fármacos
7.
Toxicon ; 130: 116-125, 2017 May.
Artigo em Inglês | MEDLINE | ID: mdl-28223047

RESUMO

Venomous animals have developed a huge arsenal of reticulated peptides for defense and predation. Based on various scaffolds, they represent a colossal pharmacological diversity, making them top candidates for the development of innovative drugs. Instead of relying on the classical, low-throughput bioassay-guided approach to identify innovative bioactive peptides, this work exploits a recent paradigm to access to venom diversity. This strategy bypasses the classical approach by combining high-throughput transcriptomics, proteomics and bioinformatics cutting-edge technologies to generate reliable peptide sequences. The strategy employed to generate hundreds of reliable sequences from Conus venoms is deeply described. The study led to the discovery of (i) conotoxins that belong to known pharmacological families targeting various GPCRs or ion-gated channels, and (ii) new families of conotoxins, never described to date. It also focusses on the diversity of genes, sequences, folds, and PTM's provided by such species.


Assuntos
Venenos de Moluscos/química , Processamento de Proteína Pós-Traducional , Animais , Cromatografia Líquida , Biologia Computacional/métodos , Caramujo Conus/metabolismo , Perfilação da Expressão Gênica , Venenos de Moluscos/metabolismo , Venenos de Moluscos/farmacologia , Filogenia , Isoformas de Proteínas , Proteômica/métodos , Análise de Sequência de RNA , Espectrometria de Massas em Tandem
8.
J Mol Biol ; 354(2): 447-58, 2005 Nov 25.
Artigo em Inglês | MEDLINE | ID: mdl-16242717

RESUMO

Toxoplasma gondii, the intracellular parasite responsible for toxoplasmosis infects more than one-third of the world population and can be life-threatening for fetuses and immunocompromised patients. The surface protein SAG1 is an important immune target, which provides a strong immune response against the invasive tachyzoite while the other forms of the parasite, devoid of SAG1 at their surface, are multiplying. In addition to this role as a "hot spot" decoy, SAG1 is predicted to act as an adhesin during host-cell attachment through its binding to proteoglycans. To begin to understand the relationships between SAG1 epitopes and the ligand-binding site, we have solved the crystal structure of the monomeric form of T.gondii SAG1 complexed to a Fab derived from a monoclonal antibody raised against tachyzoite particles. This antibody competes strongly with human Toxoplasma-specific sera, suggesting that its epitope is part of an immunodominant region present on the surface of SAG1. The structure reveals that this conformational epitope, located within the SAG1 N-terminal domain, does not overlap with the proposed ligand-binding pocket. This study provides the first structural description of the monomeric form of SAG1, and significant insights into its dual role of adhesin and immune target during parasite infection.


Assuntos
Anticorpos Monoclonais/imunologia , Antígenos de Protozoários/química , Antígenos de Protozoários/imunologia , Epitopos/análise , Fragmentos de Peptídeos/imunologia , Proteínas de Protozoários/química , Proteínas de Protozoários/imunologia , Toxoplasma/imunologia , Toxoplasmose/imunologia , Sequência de Aminoácidos , Animais , Anticorpos Antiprotozoários/imunologia , Antígenos de Protozoários/metabolismo , Antígenos de Superfície/imunologia , Sítios de Ligação , Cristalização , Cristalografia por Raios X , Humanos , Epitopos Imunodominantes , Ligantes , Camundongos , Dados de Sequência Molecular , Conformação Proteica , Proteínas de Protozoários/metabolismo , Homologia de Sequência de Aminoácidos , Toxoplasmose/genética
9.
Biol Aujourdhui ; 210(2): 89-99, 2016.
Artigo em Francês | MEDLINE | ID: mdl-27687600

RESUMO

Animal venoms are complex chemical cocktails, comprising a wide range of biologically active reticulated peptides that target with high selectivity and efficacy a variety of enzymes, membrane receptors, ion channels...Venoms can therefore be seen as large natural libraries of biologically active molecules that are continuously selected and highly refined by the evolution process, up to the point where every molecule is endowed with pharmacological properties that are highly valuable in the context of human use and drug development. Therefore, venom exploration constitutes a prerequisite to drug discovery. However, mass spectrometry and transcriptomics via NGS (Next Generation Sequencing) studies have shown the presence of up to 1000 peptides in the venom of single species of cone snails and spiders. Therefore the global animal venom resource can be seen as a collection of more than 50 to 100 000 000 peptides and proteins of which only ~5000 are known. That extraordinary "Eldorado" of bio-optimized compounds justifies the development of more global and cutting-edge strategies and technologies to explore this resource more efficiently than actually. De novo developed approaches and recently obtained results will be described.


Assuntos
Pesquisa Biomédica/métodos , Pesquisa Biomédica/tendências , Peçonhas/química , Peçonhas/farmacologia , Sequência de Aminoácidos , Animais , Descoberta de Drogas/métodos , Descoberta de Drogas/tendências , Humanos , Peptídeos/química , Peptídeos/farmacologia , Proteômica/tendências
10.
J Agric Food Chem ; 64(14): 2971-9, 2016 Apr 13.
Artigo em Inglês | MEDLINE | ID: mdl-27003441

RESUMO

Specific antibodies are essential for the immune detection of small molecule contaminants. In the present study, the heavy and light variable regions (V(H )and V(L)) of the immunoglobulin genes from a hybridoma secreting a chloramphenicol (CAP)-specific monoclonal antibody (mAb) were cloned and sequenced. In addition, the light and heavy chains obtained from the monoclonal antibody were separated using SDS-PAGE and analyzed using Orbitrap mass spectrometry. The results of DNA sequencing and mass spectrometry analysis were compared, and the V(H) and V(L) chains specific for CAP were determined and used to construct a single-chain variable fragment (scFv). This fragment was recombinantly expressed as a soluble scFv-alkaline phosphatase fusion protein and used to develop a direct competitive ELISA. Compared with the parent mAb, scFv exhibits lower sensitivity but better food matrix resistance. This work highlights the application of engineered antibodies for CAP detection.


Assuntos
Cloranfenicol/análise , Ensaio de Imunoadsorção Enzimática/métodos , Anticorpos de Cadeia Única/análise , Anticorpos Monoclonais/análise , Anticorpos Monoclonais/genética , Anticorpos Monoclonais/metabolismo , Eletroforese em Gel de Poliacrilamida , Humanos , Anticorpos de Cadeia Única/genética , Anticorpos de Cadeia Única/metabolismo
11.
MAbs ; 8(7): 1371-1385, 2016 10.
Artigo em Inglês | MEDLINE | ID: mdl-27390909

RESUMO

Metastatic melanoma is an aggressive cancer with a poor prognostic, and the design of new targeted drugs to treat melanoma is a therapeutic challenge. A promising approach is to produce monoclonal antibodies (mAbs) against the endothelin B receptor (ETB), which is known to be overexpressed in melanoma and to contribute to proliferation, migration and vasculogenic mimicry associated with invasiveness of this cancer. We previously described rendomab-B1, a mAb produced by DNA immunization. It is endowed with remarkable characteristics in term of affinity, specificity and antagonist properties against human ETB expressed by the endothelial cells, but, surprisingly, had poor affinity for ETB expressed by melanoma cells. This characteristic strongly suggested the existence of a tumor-specific ETB form. In the study reported here, we identified a new mAb, rendomab-B4, which, in contrast to rendomab-B1, binds ETB expressed on UACC-257, WM-266-4 and SLM8 melanoma cells. Moreover, after binding to UACC-257 cells, rendomab-B4 is internalized and colocalizes with the endosomal protein EEA-1. Interestingly, rendomab-B4, despite its inability to compete with endothelin binding, is able to inhibit phospholipase C pathway and migration induced by endothelin. By contrast, rendomab-B4 fails to decrease ERK1/2 phosphorylation induced by endothelin, suggesting a biased effect on ETB. These particular properties make rendomab-B4 an interesting tool to analyze ETB-structure/function and a promising starting point for the development of new immunological tools in the field of melanoma therapeutics.


Assuntos
Anticorpos Monoclonais/farmacologia , Antineoplásicos/farmacologia , Antagonistas do Receptor de Endotelina B/farmacologia , Melanoma , Receptor de Endotelina B/imunologia , Linhagem Celular Tumoral , Humanos
12.
Toxins (Basel) ; 8(7)2016 07 11.
Artigo em Inglês | MEDLINE | ID: mdl-27409637

RESUMO

Sarafotoxins (SRTX) are endothelin-like peptides extracted from the venom of snakes belonging to the Atractaspididae family. A recent in vivo study on anesthetized and ventilated animals showed that sarafotoxin-b (SRTX-b), extracted from the venom of Atractaspis engaddensis, decreases cardiac output by inducing left ventricular dysfunction while sarafotoxin-m (SRTX-m), extracted from the venom of Atractaspis microlepidota microlepidota, induces right ventricular dysfunction with increased airway pressure. The aim of the present experimental study was to compare the respiratory effects of SRTX-m and SRTX-b. Male Wistar rats were anesthetized, tracheotomized and mechanically ventilated. They received either a 1 LD50 IV bolus of SRTX-b (n = 5) or 1 LD50 of SRTX-m (n = 5). The low-frequency forced oscillation technique was used to measure respiratory impedance. Airway resistance (Raw), parenchymal damping (G) and elastance (H) were determined from impedance data, before and 5 min after SRTX injection. SRTX-m and SRTX-b injections induced acute hypoxia and metabolic acidosis with an increased anion gap. Both toxins markedly increased Raw, G and H, but with a much greater effect of SRTX-b on H, which may have been due to pulmonary edema in addition to bronchoconstriction. Therefore, despite their structural analogy, these two toxins exert different effects on respiratory function. These results emphasize the role of the C-terminal extension in the in vivo effect of these toxins.


Assuntos
Sistema Respiratório/efeitos dos fármacos , Doenças Respiratórias/induzido quimicamente , Venenos de Víboras/toxicidade , Viperidae , Equilíbrio Ácido-Base/efeitos dos fármacos , Acidose/induzido quimicamente , Acidose/fisiopatologia , Resistência das Vias Respiratórias/efeitos dos fármacos , Animais , Broncoconstrição/efeitos dos fármacos , Hipóxia/induzido quimicamente , Hipóxia/fisiopatologia , Dose Letal Mediana , Complacência Pulmonar/efeitos dos fármacos , Masculino , Edema Pulmonar/induzido quimicamente , Edema Pulmonar/fisiopatologia , Ratos Wistar , Sistema Respiratório/fisiopatologia , Doenças Respiratórias/fisiopatologia , Viperidae/classificação
13.
PLoS One ; 10(7): e0132864, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-26176218

RESUMO

UNLABELLED: Sarafotoxin-m (24 amino acids) from the venom of Atractaspis microlepidota microlepidota was the first long-sarafotoxin to be identified, while sarafotoxin-b (21 aa) is a short-sarafotoxin from Atractaspis engaddensis. Despite the presence of three additional C-terminus residues in sarafotoxin-m, these two peptides display a high sequence homology and share similar three-dimensional structures. However, unlike sarafotoxin-b, sarafotoxin-m shows a very low in vitro affinity for endothelin receptors, but still has a very high in vivo toxicity in mammals, similar to that of sarafotoxin-b. We have previously demonstrated, in vitro, the crucial role of the C-terminus extension in terms of pharmacological profiles and receptor affinities of long- versus short-sarafotoxins. One possible hypothesis to explain the high in vivo toxicity of sarafotoxin-m could be that its C-terminus extension is processed in vivo, resulting in short-like sarafotoxin. To address this possibility, we investigated, in the present study, the in vivo cardiovascular effects of sarafotoxin-b, sarafotoxin-m and sarafotoxin-m-Cter (sarafotoxin-m without the C -terminus extension). Male Wistar rats were anaesthetised and mechanically ventilated. Invasive haemodynamic measurements and echocardiographic measurements of left and right ventricular function were performed. The rats were divided into four groups that respectively received intravenous injections of: saline, sarafotoxin-b (one LD50), sarafotoxin-m (one LD50) or sarafotoxin-m-Cter (one LD50). All measurements were performed at baseline, at 1 minute (+1) and at 6 minutes (+6) after injection. RESULTS: Sarafotoxin-b and sarafotoxin-m-Cter decreased cardiac output and impaired left ventricle systolic and diastolic function, whilst sarafotoxin-m decreased cardiac output, increased airway pressures and led to acute right ventricular dilatation associated with a decreased tricuspid annulus peak systolic velocity. Sarafotoxin-b and sarafotoxin-m-Cter appear to exert toxic effects via impairment of left ventricular function, whilst sarafotoxin-m increases airway pressures and impairs right ventricular function. These results do not support the hypothesis of an in vivo processing of long sarafotoxins.


Assuntos
Hemodinâmica/efeitos dos fármacos , Homologia Estrutural de Proteína , Venenos de Víboras/química , Venenos de Víboras/farmacologia , Animais , Ecocardiografia Doppler , Eletrocardiografia , Frequência Cardíaca/efeitos dos fármacos , Pulmão/efeitos dos fármacos , Masculino , Pressão , Ratos Wistar , Reprodutibilidade dos Testes , Função Ventricular/efeitos dos fármacos
14.
Gene ; 299(1-2): 263-70, 2002 Oct 16.
Artigo em Inglês | MEDLINE | ID: mdl-12459274

RESUMO

Transaldolase (TAL) is an enzyme of the non-oxidative part of the pentose phosphate pathway which produces reductive potential in the form of NADPH as well as ribose 5-phosphate for incorporation into nucleotides. Developmental analysis via reverse transcriptase-polymerase chain reaction, immunoblots, enzymatic activity, in situ hybridization and immunocytochemistry demonstrate that TAL is expressed during all developmental stages in Drosophila. The tal locus is unique and contains two small introns. The first two introns in the human gene are situated at the same locations in the coding sequence as in Drosophila. Analysis of TAL protein levels and expression patterns reveals that it is also expressed in all larval tissues examined with particularly high levels in the fat body. Interestingly, we describe specific TAL expression only in non-neuronal cells in the larval brain.


Assuntos
Drosophila/genética , Transaldolase/genética , Sequência de Aminoácidos , Animais , Sequência de Bases , Western Blotting , Drosophila/embriologia , Drosophila/enzimologia , Embrião não Mamífero/enzimologia , Embrião não Mamífero/metabolismo , Desenvolvimento Embrionário , Éxons , Feminino , Regulação da Expressão Gênica no Desenvolvimento , Regulação Enzimológica da Expressão Gênica , Genes de Insetos/genética , Hibridização In Situ , Íntrons , Masculino , Dados de Sequência Molecular , Transaldolase/metabolismo
15.
Peptides ; 25(8): 1243-51, 2004 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-15350691

RESUMO

Sarafotoxins (SRTXs) constitute a family of vasoactive peptides that were initially isolated from the venom of Atractaspis engaddensis, and that are structurally and functionally related to endothelins (ETs). Analysis of the venom of Atractaspis microlepidota microlepidota revealed several new SRTX molecules manifesting some new structural and functional characteristics. These novel SRTXs are longer by three amino acids than the previously described SRTXs, and are designated here "long-SRTXs". Six isoforms, derived from new poly-cistronic precursors, have been identified so far in the venom of this snake. One of these isoforms, designated SRTX-m, was chemically synthesized and its biological properties were studied. Our results show that SRTX-m induces toxicity in mice, mostly due to vasoconstriction, and also that it has a lower toxicity and potency than the more potent SRTX described up to now: sarafotoxin-b (SRTX-b) from A. engaddensis.


Assuntos
Endotelinas/química , Peptídeos/química , Venenos de Víboras/química , Sequência de Aminoácidos , Animais , Relação Dose-Resposta a Droga , Endotelinas/toxicidade , Frequência Cardíaca/efeitos dos fármacos , Camundongos , Dados de Sequência Molecular , Contração Muscular/efeitos dos fármacos , Peptídeos/genética , Peptídeos/toxicidade , Isoformas de Proteínas/química , Isoformas de Proteínas/genética , Isoformas de Proteínas/toxicidade , Coelhos , Serpentes , Vasoconstritores/química , Vasoconstritores/toxicidade , Venenos de Víboras/genética , Venenos de Víboras/toxicidade
16.
Methods Mol Biol ; 267: 101-12, 2004.
Artigo em Inglês | MEDLINE | ID: mdl-15269418

RESUMO

The methods described in this article are relative to the use of a positive cloning/screening recombinant system for the generation in Escherichia coli of foreign proteins fused to a highly active bacterial alkaline phosphatase (PhoA) variant as reporter enzyme. Appropriate insertion of the DNA encoding the foreign peptides, proteic domains, or proteins between codons +6 and +7 of the phoa gene restores the initial frame of the phoa gene in the vector. Consequently, only recombinant clones appear as blue colonies when plating onto an agar medium containing a chromogenic substrate for PhoA. The presence of an intact PhoA signal peptide yields to a systematic secretion of the fusion proteins into the periplasm where the PhoA dimerises to its active form, and disulfides can be formed if necessary. The resultant PhoA-tagged proteins are particularly convenient novel tools that can be used in a wide range of applications, including expression, epitope mapping, histochemistry, immunoblotting, mutant analysis, and competition or sandwich ELISAs. Expression of an scFv antibody fragment derived from an IgG2a/kappa immunoglobulin specific for curaremimetic toxins from snake (named M-alpha2-3), will be used to illustrate the methods utilized for its cloning, expression in E.coli, extraction, and functional characterization.


Assuntos
Fosfatase Alcalina/genética , Clonagem Molecular/métodos , Escherichia coli/genética , Proteínas Recombinantes de Fusão/genética , Fosfatase Alcalina/biossíntese , Western Blotting/métodos , Ensaio de Imunoadsorção Enzimática/métodos , Escherichia coli/metabolismo , Região Variável de Imunoglobulina/biossíntese , Região Variável de Imunoglobulina/genética , Proteínas Recombinantes de Fusão/biossíntese
17.
Future Med Chem ; 6(15): 1629-43, 2014 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-25406004

RESUMO

Over the last three decades, transcriptomic studies of venom gland cells have continuously evolved, opening up new possibilities for exploring the molecular diversity of animal venoms, a prerequisite for the discovery of new drug candidates and molecular phylogenetics. The molecular complexity of animal venoms is much greater than initially thought. In this review, we describe the different technologies available for transcriptomic studies of venom, from the original individual cloning approaches to the more recent global Next Generation Sequencing strategies. Our understanding of animal venoms is evolving, with the discovery of complex and diverse bio-optimized cocktails of compounds, including mostly peptides and proteins, which are now beginning to be studied by academic and industrial researchers.


Assuntos
Transcriptoma , Peçonhas/metabolismo , Animais , Descoberta de Drogas , Etiquetas de Sequências Expressas , Perfilação da Expressão Gênica , Sequenciamento de Nucleotídeos em Larga Escala , Humanos , Dor/tratamento farmacológico , Peçonhas/uso terapêutico
18.
Toxicon ; 70: 70-81, 2013 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-23584016

RESUMO

Animal venoms are complex mixtures containing a range of bioactive elements with potential pharmacological and therapeutic use. Even though ants account among the most diverse zoological group, little information is available regarding their venom composition. To initiate the characterization of the transcriptomic venom gland expression of the ant species Tetramorium bicarinatum, 400 randomly selected clones from cDNA library were sequenced and a total of 364 high quality expressed sequence tags (ESTs) were generated. Based on the results of BLAST searches, these sequences were clustered and assembled into 83 contigs (22 multiple sequences) and 61 singletons. About 74% (267) of the contigs matched BLASTx hits with an interesting diversity together with an unusual abundance of cellular transcripts related to gene expression regulation (29% of the total library) reflecting the specialization of this tissue. About eighteen per cent of the ESTs were categorized as Hymenoptera venom compounds, the major part represented by allergens (62% of the total venom compounds). In addition, a high number of sequences (26%) had no similarity to any known sequences. This study provides a first insight of the gene expression scenario of the venom gland of T. bicarinatum which might contribute to acquiring a more comprehensive view on the origin and functional diversity of venom proteins among ants and more broadly among Hymenopteran insects.


Assuntos
Formigas/genética , Transcriptoma , Peçonhas/química , Peçonhas/genética , Sequência de Aminoácidos , Animais , Glândulas Exócrinas/química , Etiquetas de Sequências Expressas , Perfilação da Expressão Gênica , Regulação da Expressão Gênica , Biblioteca Gênica , Proteínas de Insetos/química , Proteínas de Insetos/genética , Dados de Sequência Molecular , Família Multigênica , Alinhamento de Sequência , Análise de Sequência de DNA
19.
Toxins (Basel) ; 5(11): 1948-64, 2013 Oct 28.
Artigo em Inglês | MEDLINE | ID: mdl-24169588

RESUMO

Although snake venoms have been the subject of intense research, primarily because of their tremendous potential as a bioresource for design and development of therapeutic compounds, some specific groups of snakes, such as the genus Atractaspis, have been completely neglected. To date only limited number of toxins, such as sarafotoxins have been well characterized from this lineage. In order to investigate the molecular diversity of venom from Atractaspis aterrima-the slender burrowing asp, we utilized a high-throughput transcriptomic approach completed with an original bioinformatics analysis pipeline. Surprisingly, we found that Sarafotoxins do not constitute the major ingredient of the transcriptomic cocktail; rather a large number of previously well-characterized snake venom-components were identified. Notably, we recovered a large diversity of three-finger toxins (3FTxs), which were found to have evolved under the significant influence of positive selection. From the normalized and non-normalized transcriptome libraries, we were able to evaluate the relative abundance of the different toxin groups, uncover rare transcripts, and gain new insight into the transcriptomic machinery. In addition to previously characterized toxin families, we were able to detect numerous highly-transcribed compounds that possess all the key features of venom-components and may constitute new classes of toxins.


Assuntos
Evolução Molecular , Venenos de Serpentes/genética , Venenos de Serpentes/isolamento & purificação , Serpentes , Sequência de Aminoácidos , Animais , Biologia Computacional , DNA Complementar/genética , Sequenciamento de Nucleotídeos em Larga Escala , Dados de Sequência Molecular , Conformação Proteica , Seleção Genética , Transcriptoma
20.
J Immunol Methods ; 387(1-2): 11-20, 2013 Jan 31.
Artigo em Inglês | MEDLINE | ID: mdl-22910001

RESUMO

Prescription of therapeutic antibodies has radically modified the prognosis of some important diseases. However, the very high cost of these new drugs is a problem for public health organizations, which require assessment of the effectiveness of the antibody for each patient before beginning or during the treatment. In vivo immunoimaging is particularly well adapted to meet this demand. However, full-length antibodies are unsuitable for in vivo imaging due to their persistence in the serum and must be engineered in smaller formats to improve their pharmacokinetic properties without modifying their affinity and specificity. The small bivalent antibody fragment called diabody perfectly meets these in vivo imaging requirements. However, obtaining diabodies is laborious, time-consuming and sometimes unsuccessful. Using a diabody derived from a monoclonal antibody (12G4) directed against the human anti-Müllerian hormone receptor, a biomarker of ovarian cancers for which therapeutic antibodies are already undergoing clinical trials, we describe here a new diabody refolding protocol with various reducing conditions. Diabody functionality was checked in vitro and ex vivo with, respectively, a new immunoassay involving the epitopic peptide as a tracer and flow cytometry experiments with cells expressing recombinant anti-Müllerian hormone receptors. Our optimized protocol allows us to find the best refolding conditions for each diabody and to obtain large amounts of functional diabodies.


Assuntos
Anticorpos Biespecíficos/imunologia , Anticorpos Monoclonais/imunologia , Neoplasias Ovarianas/imunologia , Receptores de Peptídeos/imunologia , Receptores de Fatores de Crescimento Transformadores beta/imunologia , Sequência de Aminoácidos , Anticorpos Biespecíficos/genética , Anticorpos Biespecíficos/metabolismo , Anticorpos Monoclonais/genética , Anticorpos Monoclonais/metabolismo , Especificidade de Anticorpos/imunologia , Sequência de Bases , Eletroforese em Gel de Poliacrilamida , Ensaio de Imunoadsorção Enzimática/métodos , Epitopos/imunologia , Epitopos/metabolismo , Escherichia coli/genética , Escherichia coli/metabolismo , Feminino , Citometria de Fluxo , Expressão Gênica , Humanos , Corpos de Inclusão/metabolismo , Dados de Sequência Molecular , Neoplasias Ovarianas/diagnóstico , Neoplasias Ovarianas/terapia , Ligação Proteica/imunologia , Redobramento de Proteína , Proteínas Recombinantes/química , Proteínas Recombinantes/imunologia , Proteínas Recombinantes/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA